Ergoteles LLC Pds Biotechnology Corp Transaction History
Ergoteles LLC
- $68.2 Billion
- Q3 2023
Shares
2 transactions
Others Institutions Holding PDSB
# of Institutions
76Shares Held
7.53MCall Options Held
140KPut Options Held
318K-
Black Rock Inc. New York, NY1.87MShares$5.66 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.59MShares$4.81 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA654KShares$1.98 Million0.0% of portfolio
-
State Street Corp Boston, MA557KShares$1.69 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC355KShares$1.08 Million0.23% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $86.2M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...